Inventor · disambiguated record
Songchun Jiang
Also filed as: JIANG SONGCHUN
16 granted patents·19 pending applications·150 citations·filing 2002–2024
92Inventor score
Top patents by PatentIndex Score
35 records- 0192US7618975B24-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofMYRIAD PHARMACEUTICALS INC·Filed 2004·Granted Nov 17, 2009·61 cites·48 claims
- 0290US8519129B2Pyrimidine derivatives as kinase inhibitorsMARSILJE THOMAS H III·Filed 2009·Granted Aug 27, 2013·33 cites·11 claims
- 0389US7678792B2Compositions and methods for modulating c-kit and PDGFR receptorsIRM LLC·Filed 2007·Granted Mar 16, 2010·13 cites·17 claims
- 0482US8153635B2Compounds and compositions as modulators of GPR119 activityALPER PHILLIP B·Filed 2008·Granted Apr 10, 2012·7 cites·17 claims
- 0580US7015328B2Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereofSHIRE BIOCHEM INC·Filed 2002·Granted Mar 21, 2006·9 cites·19 claims
- 0679US7622497B2Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2004·Granted Nov 24, 2009·7 cites·4 claims
- 0777US2024376099A1Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0876US7235674B2Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Granted Jun 26, 2007·6 cites·1 claims
- 0975US8026243B2[4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitorsNOVARTIS AG·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 1072US8445505B2Pyrimidine derivatives as kinase inhibitorsMARSILJE III THOMAS H·Filed 2009·Granted May 21, 2013·2 cites·8 claims
- 1171US7842805B2Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereofMYREXIS INC·Filed 2007·Granted Nov 30, 2010·2 cites·14 claims
- 1269US9440957B2Compounds and compositions for modulating EGFR ActivityLELAIS GERALD·Filed 2013·Granted Sep 13, 2016·3 cites·21 claims
- 1369US7592143B2Methods of treating diseases responsive to induction of apoptosis and screening assaysCYTOVIA INC·Filed 2004·Granted Sep 22, 2009·3 cites·9 claims
- 1464US8859574B2Compounds and compositions as kinase inhibitorsMARSILJE THOMAS H·Filed 2013·Granted Oct 14, 2014·1 cites·8 claims
- 1563US2021101902A1Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1661US10954233B2Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2017·Granted Mar 23, 2021·0 cites·30 claims
- 1761US2008032974A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 1861US2008039479A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 1960US2007249601A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 2060US2007244113A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 2159US7476741B2Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2003·Granted Jan 13, 2009·1 cites·23 claims
- 2259US2007208044A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 2355US2017050937A1Compounds and therapeutical use thereofImmune pharmaceuticals inc·Filed 2016·Application pending·0 cites
- 2453US2010022515A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2008·Application pending·0 cites
- 2550US2006035925A1Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2005·Application pending·0 cites
- 2649US2011190263A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 2748US2012196844A1Compounds and compositions as modulators of gpr119 activityALPER PHILLIP B·Filed 2012·Application pending·0 cites
- 2846US2007244114A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 2944US2022071971A1Macrocyclic compounds and their use in the treatment of diseaseNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3043US7528164B2Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2003·Granted May 5, 2009·0 cites·22 claims
- 3143US2009105250A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2006·Application pending·0 cites
- 3240US2013338152A1Fluorophenyl bicyclic heteroaryl compoundsCHEN BEI·Filed 2012·Application pending·0 cites
- 3338US2015152083A1Compounds and Compositions for Modulating EGFR ActivityLELAIS GERALD·Filed 2013·Application pending·0 cites
- 3437US2012289501A1Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroarylsCHEN BEI·Filed 2010·Application pending·0 cites
- 3534US2011053897A1Compounds and compositions as syk kinase inhibitorsIRM LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Songchun Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →